Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3849-21-6

Post Buying Request

3849-21-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3849-21-6 Usage

Chemical Properties

light yellow crystals or chunks

Uses

Different sources of media describe the Uses of 3849-21-6 differently. You can refer to the following data:
1. A non-explosive alternative to HOBt.
2. This product is a non-explosive alternative to HOBt or HOAt, and allows high peptide coupling rates at low racemization when applied in combination with carbodiimides.

Check Digit Verification of cas no

The CAS Registry Mumber 3849-21-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,8,4 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 3849-21:
(6*3)+(5*8)+(4*4)+(3*9)+(2*2)+(1*1)=106
106 % 10 = 6
So 3849-21-6 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O3/c1-2-10-5(8)4(3-6)7-9/h9H,2H2,1H3/b7-4+

3849-21-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (E0847)  Ethyl Cyano(hydroxyimino)acetate  >98.0%(GC)

  • 3849-21-6

  • 25g

  • 450.00CNY

  • Detail
  • TCI America

  • (E0847)  Ethyl Cyano(hydroxyimino)acetate  >98.0%(GC)

  • 3849-21-6

  • 100g

  • 1,200.00CNY

  • Detail
  • Alfa Aesar

  • (A12691)  Ethyl isonitrosocyanoacetate, 97%   

  • 3849-21-6

  • 5g

  • 159.0CNY

  • Detail
  • Alfa Aesar

  • (A12691)  Ethyl isonitrosocyanoacetate, 97%   

  • 3849-21-6

  • 25g

  • 456.0CNY

  • Detail
  • Alfa Aesar

  • (A12691)  Ethyl isonitrosocyanoacetate, 97%   

  • 3849-21-6

  • 100g

  • 1549.0CNY

  • Detail
  • Aldrich

  • (233412)  Ethyl(hydroxyimino)cyanoacetate  97%

  • 3849-21-6

  • 233412-50G

  • 1,571.31CNY

  • Detail
  • Aldrich

  • (233412)  Ethyl(hydroxyimino)cyanoacetate  97%

  • 3849-21-6

  • 233412-250G

  • 5,663.97CNY

  • Detail

3849-21-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl cyanoglyoxylate-2-oxime

1.2 Other means of identification

Product number -
Other names Cyano(hydroxyimino)acetic Acid Ethyl Ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3849-21-6 SDS

3849-21-6Synthetic route

ethyl 2-cyanoacetate
105-56-6

ethyl 2-cyanoacetate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
Stage #1: ethyl 2-cyanoacetate With acetic acid In water at 0℃; for 0.166667h;
Stage #2: With sodium nitrite In water at 0 - 20℃; for 6.5h;
97%
With sodium hydroxide; water; acetic acid; sodium nitrite for 3h; Ambient temperature;92%
With acetic acid; sodium nitrite In water at 0 - 27℃; for 2h; Industry scale;91.2%
ethyl 2-cyanoacetate
105-56-6

ethyl 2-cyanoacetate

isopentyl nitrite
110-46-3

isopentyl nitrite

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With ethanol; sodium ethanolate
ethyl cyanoacetate anion
31124-95-5

ethyl cyanoacetate anion

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With nitrosyl thiocyanate In 1,4-dioxane; water at 25℃; Rate constant;
β-oxy-β-ethoxy-α-hydroxyimino-β-amino-propionitrile

β-oxy-β-ethoxy-α-hydroxyimino-β-amino-propionitrile

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With hydrogenchloride
bis-<α-oxy-α-ethoxy-β-hydroxyimino-β-cyano-ethyl>-amine

bis-<α-oxy-α-ethoxy-β-hydroxyimino-β-cyano-ethyl>-amine

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With hydrogenchloride
C12H19N4O4

C12H19N4O4

A

N,N-dimethyl-4-morpholinecarboxamide
38952-61-3

N,N-dimethyl-4-morpholinecarboxamide

B

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With water In N,N-dimethylformamide-D7
1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate

1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate

A

N,N-dimethyl-4-morpholinecarboxamide
38952-61-3

N,N-dimethyl-4-morpholinecarboxamide

B

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

Conditions
ConditionsYield
With N,N-dimethyl-formamide for 48h; Reagent/catalyst; Time;
(E)-4-methyl-3,5-hexadienoic acid
95421-98-0

(E)-4-methyl-3,5-hexadienoic acid

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

cyano-(1-oxo-4-methylhexa-3(E),5-dienyloxyimino)acetic acid ethyl ester

cyano-(1-oxo-4-methylhexa-3(E),5-dienyloxyimino)acetic acid ethyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Acylation;100%
(E)-3,5-hexadienoic acid
32775-95-4

(E)-3,5-hexadienoic acid

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

cyano-(1-oxo-hexa-3,5-dienyloxyimino)acetic acid ethyl ester

cyano-(1-oxo-hexa-3,5-dienyloxyimino)acetic acid ethyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 2h; Acylation;97%
ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl-2-aminocyano acetate
32683-02-6

ethyl-2-aminocyano acetate

Conditions
ConditionsYield
With platinum on activated charcoal; hydrogen In ethanol at 25℃; under 7500.75 Torr; for 48h;96%
With hydrogen; platinum(IV) oxide In ethanol under 3000.3 Torr;91%
With platinum(IV) oxide; hydrogen In ethanol under 3000.3 Torr;89%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl 2-(tert-butoxycarbonyloxyimino)-2-cyanoacetate

ethyl 2-(tert-butoxycarbonyloxyimino)-2-cyanoacetate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In chloroform at 0 - 5℃; for 1h;96%
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 35℃; for 3.5h; Inert atmosphere;93%
With N-ethyl-N,N-diisopropylamine In chloroform at 0 - 5℃; for 1h;
ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

7-phenyl-4(E),6(E)-heptanedienoic acid

7-phenyl-4(E),6(E)-heptanedienoic acid

cyano-(2-oxo-7-phenylhepta-4(E),6(E)-dienyloxyimino)acetic acid ethyl ester

cyano-(2-oxo-7-phenylhepta-4(E),6(E)-dienyloxyimino)acetic acid ethyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 3.5h; Acylation;95%
C18H27N4O3Pol

C18H27N4O3Pol

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

A

H-MeGly-Phe-Leu-NH2
1195983-87-9

H-MeGly-Phe-Leu-NH2

B

C19H28N4O4

C19H28N4O4

C

C23H34N6O6

C23H34N6O6

Conditions
ConditionsYield
Stage #1: C18H27N4O3Pol; N,N-dimethyl-formamide; ethyl cyanoglyoxylate-2-oxime at 80℃; for 0.166667h; Microwave irradiation; solid phase reaction;
Stage #2: With water; trifluoroacetic acid at 20℃; for 1h; solid phase reaction;
A 94.5%
B 4%
C 1.5%
Allyl chloroformate
2937-50-0

Allyl chloroformate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl 2-(allyloxycarbonyloxyimino)-2-cyanoacetate
41844-53-5

ethyl 2-(allyloxycarbonyloxyimino)-2-cyanoacetate

Conditions
ConditionsYield
With sodium carbonate In dichloromethane; water at 0 - 20℃; for 2.5h;94%
silver nitrate

silver nitrate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

silver(I) α-oximido-(ethylacetoxy)acetonitrile
950847-32-2

silver(I) α-oximido-(ethylacetoxy)acetonitrile

Conditions
ConditionsYield
In ethanol; water byproducts: CO2; Sonication; a ligand (2.46 mM) in a mixt. of EtOH and H2O was heated to +50°Cand then added dropwise to an aq. soln. of K2CO3 (1.22 mM); sonication for 2 min; an aq. soln. of AgNO3 (2.46 mmol) was added dropwise; stirrin g for 20 min; the ppt. was filtered, washed with water and dried in a vac. desiccator charged with concd. H2SO4 for 3 d; elem. anal.;93%
ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

isobutyl chloroformate
543-27-1

isobutyl chloroformate

ethyl 2-cyano-2-(isobutoxycarbonyloxyimino)acetate
41844-54-6

ethyl 2-cyano-2-(isobutoxycarbonyloxyimino)acetate

Conditions
ConditionsYield
With sodium carbonate In dichloromethane; water at 0 - 20℃; for 2.5h;93%
tert-butyl bromoisobutyrate
23877-12-5

tert-butyl bromoisobutyrate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

C13H20N2O5

C13H20N2O5

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 20 - 35℃; under 760.051 Torr; for 8h; Temperature; Reagent/catalyst;92.6%
2-thiazolylamine
96-50-4

2-thiazolylamine

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

5-imino-6-isonitrosothiazolo<3,2-a>pyrimidin-7-one
174279-85-7

5-imino-6-isonitrosothiazolo<3,2-a>pyrimidin-7-one

Conditions
ConditionsYield
With sodium ethanolate In ethanol for 3h; Heating;92%
2-Naphthalenesulfonyl chloride
93-11-8

2-Naphthalenesulfonyl chloride

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl 2-cyano-2-(naphthalen-2-ylsulfonyloxyimino)acetate
1243301-73-6

ethyl 2-cyano-2-(naphthalen-2-ylsulfonyloxyimino)acetate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;92%
Stage #1: ethyl cyanoglyoxylate-2-oxime With triethylamine In dichloromethane at 0℃; Inert atmosphere;
Stage #2: 2-Naphthalenesulfonyl chloride In dichloromethane at 0 - 20℃; for 2.5h; Inert atmosphere;
92%
(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

diethyl 2-{[(9H-fluoren-9-yl)methoxy]carbonyloxyimino}-2-cyanoacetate
1235983-26-2

diethyl 2-{[(9H-fluoren-9-yl)methoxy]carbonyloxyimino}-2-cyanoacetate

Conditions
ConditionsYield
With sodium carbonate In dichloromethane; water at 0 - 20℃;91%
1-chloro-2,4-dinitro-benzene
97-00-7

1-chloro-2,4-dinitro-benzene

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl cyano(2,4-dinitrophenoxyimino)acetate
1346257-79-1

ethyl cyano(2,4-dinitrophenoxyimino)acetate

Conditions
ConditionsYield
Stage #1: ethyl cyanoglyoxylate-2-oxime With sodium hydroxide In acetonitrile Heating;
Stage #2: 1-chloro-2,4-dinitro-benzene In acetonitrile at 20℃;
90.9%
1-[chloro(morpholino)methylene]pyrrolidinium hexafluorophosphate

1-[chloro(morpholino)methylene]pyrrolidinium hexafluorophosphate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

1-((1-cyano-2-ethoxy-2-oxoethylideneaminooxy)(morpholino)methylene)pyrrolidinium hexafluorophosphate

1-((1-cyano-2-ethoxy-2-oxoethylideneaminooxy)(morpholino)methylene)pyrrolidinium hexafluorophosphate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;90.3%
(E,E)-4,6-heptadienoic acid
75283-35-1

(E,E)-4,6-heptadienoic acid

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

2-cyano-((E)-2-oxo-hepta-4,6-dienyloxyimino)acetic acid ethyl ester

2-cyano-((E)-2-oxo-hepta-4,6-dienyloxyimino)acetic acid ethyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 1h; Acylation;90%
4-[(dimethylamino)chloromethylene]morpholin-4-iminium hexafluorophosphate

4-[(dimethylamino)chloromethylene]morpholin-4-iminium hexafluorophosphate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate

1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;88.8%
N-(2-phenylethyl)thiourea
6815-00-5

N-(2-phenylethyl)thiourea

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

6-amino-2-mercapto-5-nitroso-1-(2-phenylethyl)-4(1H)-pyrimidinone
139460-80-3

6-amino-2-mercapto-5-nitroso-1-(2-phenylethyl)-4(1H)-pyrimidinone

Conditions
ConditionsYield
With sodium ethanolate In 2-methoxy-ethanol for 5.5h; Heating;88.7%
ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

6-methyl-4,6-heptadienoic acid

6-methyl-4,6-heptadienoic acid

cyano-(2-oxo-6-methylhepta-4,6-dienyloxyimino)acetic acid ethyl ester

cyano-(2-oxo-6-methylhepta-4,6-dienyloxyimino)acetic acid ethyl ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane for 2.5h; Acylation;88%
2-chloro-5-nitropyridine
4548-45-2

2-chloro-5-nitropyridine

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl cyano(5-nitro-2-pyridyloxyimino)acetate
1346257-84-8

ethyl cyano(5-nitro-2-pyridyloxyimino)acetate

Conditions
ConditionsYield
Stage #1: ethyl cyanoglyoxylate-2-oxime With sodium hydroxide In acetonitrile Heating;
Stage #2: 2-chloro-5-nitropyridine In acetonitrile at 20℃;
87.06%
benzyl chloroformate
501-53-1

benzyl chloroformate

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl 2-(benzyloxycarbonyloxyimino)-2-cyanoacetate
41875-37-0

ethyl 2-(benzyloxycarbonyloxyimino)-2-cyanoacetate

Conditions
ConditionsYield
With sodium carbonate In dichloromethane; water at 0 - 20℃; for 2.5h;87%
p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl 2-cyano-2-(tosyloxyimino)acetate
40559-90-8

ethyl 2-cyano-2-(tosyloxyimino)acetate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere;86%
Stage #1: ethyl cyanoglyoxylate-2-oxime With triethylamine In dichloromethane at 0℃; Inert atmosphere;
Stage #2: p-toluenesulfonyl chloride In dichloromethane at 0 - 20℃; for 2.5h; Inert atmosphere;
85%
2-chloro-4,6-dimethoxy-1 ,3,5-triazine
3140-73-6

2-chloro-4,6-dimethoxy-1 ,3,5-triazine

ethyl cyanoglyoxylate-2-oxime
3849-21-6

ethyl cyanoglyoxylate-2-oxime

ethyl-2-cyano-2-(4,6-dimethoxy-1,3,5-triazin-2-yloxyimino)acetate
1259296-13-3

ethyl-2-cyano-2-(4,6-dimethoxy-1,3,5-triazin-2-yloxyimino)acetate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃;86%

3849-21-6Relevant articles and documents

Re-evaluating the stability of COMU in different solvents

Kumar, Ashish,Jad, Yahya E.,de la Torre, Beatriz G.,El-Faham, Ayman,Albericio, Fernando

, p. 763 - 768 (2017)

COMU is uronium-type coupling reagent based on OxymaPure. It showed several advantages over classical benzotriazole-based coupling reagents such as higher solubility, water-soluble byproduct, and monitoring the reaction by changing of color. Although COMU is well known to perform excellent in solution, but its hydrolytic stability in DMF limits its use in automatic peptide synthesizer. Herein, we evaluated the hydrolytic stability of COMU in γ-valerolactone (GVL), acetonitrile (ACN) and N-formylmorpholine (NFM) and compared its stability against DMF. The stability of COMU after 24?h was found to be 88 and 89% in GVL and ACN, respectively, when compared in DMF (14%). Further, the demanding Aib-ACP decapeptide and JR decapeptide were successfully synthesized using COMU dissolved in GVL or ACN while Fmoc amino acids were dissolved in DMF. Copyright

1,3,4-Oxadiazole Bridges: A Strategy to Improve Energetics at the Molecular Level

Ma, Jinchao,Chinnam, Ajay Kumar,Cheng, Guangbin,Yang, Hongwei,Zhang, Jiaheng,Shreeve, Jean'ne M.

, p. 5497 - 5504 (2021/01/26)

Many energetic materials synthesized to date have limited applications because of low thermal and/or mechanical stability. This limitation can be overcome by introducing structural modifications such as a bridging group. In this study, a series of 1,3,4-oxadiazole-bridged furazans was prepared. Their structures were confirmed by 1H and 13C NMR, infrared, elemental, and X-ray crystallographic analyses. The thermal stability, friction sensitivity, impact sensitivity, detonation velocity, and detonation pressure were evaluated. The hydroxylammonium salt 8 has an excellent detonation performance (D=9101 m s?1, P=37.9 GPa) and insensitive properties (IS=17.4 J, FS=330 N), which show its great potential as a high-performance insensitive explosive. Using quantum computation and crystal structure analysis, the effect of the introduction of the 1,3,4-oxadiazole moiety on molecular reactivity and the difference between the sensitivities and thermal stabilities of mono- and bis-1,3,4-oxadiazole bridges are considered. The synthetic method for introducing 1,3,4-oxadiazole and the systematic study of 1,3,4-oxadiazole-bridged compounds provide a theoretical basis for future energetics design.

Tetrahydrooxazolopyridino-oxaazaone derivative and application of tetrahydrooxazolopyridino-oxaazaone derivative

-

Paragraph 0104; 0107-0109, (2021/05/12)

The invention relates to a tetrahydrooxazolopyridino-oxaazaone derivative and application thereof. Specifically, the derivative tetrahydrooxazolo[5',4' : 4,5]pyridino[1, 2-a]oxaaza-11(5H)-one derivatives E1-E48. In anti-tumor activity screening, the positive control of DOX is used; the inhibition effect of the 48 tetrahydrooxazolo[5',4':4,5]pyridino[1, 2-a]oxaaza-11(5H)-one derivatives E1-E48 on Hela human cervical cancer cells, MCF-7 breast cancer cells and A549 lung cancer cells is observed, and the results show that compared with the positive control, the compounds E5, E8, E9, E20, E26, E28, E32, E34, E38, E41, E42, E44, E45, E46, E47 and E48 have the inhibition activity on the Hela cervical cancer cells, the compounds E26, E38, E42, E45, E46 and E47 have inhibitory activity on MCF-7 breast cancer cells; and the compounds E8, E9, E26 and E47 have inhibitory activity on A549 lung cancer cells.

Synthesis and anticancer activity of ethyl 5-amino-1-N-substituted-imidazole-4-carboxylate building blocks

Ruzi, Zukela,Nie, Lifei,Bozorov, Khurshed,Zhao, Jiangyu,Aisa, Haji A.

, (2021/05/27)

A series of 5-amino-1-N-substituted-imidazole-4-carboxylate building blocks was synthesized and assayed for their antiproliferative potential against human cancer cell lines, including HeLa (cervical), HT-29, HCT-15 (colon), A549 (lung), and MDA-MB-231 (breast) cells. The preliminary screening results revealed that several derivatives containing alkyl chains at the N-1 position of the imidazole core demonstrate a certain inhibitory effect on growth and proliferation. A significant effect was observed following ethyl 5-amino-1-dodecyl-1H-imidazole-4-carboxylate (5e) treatment for 72 h. The IC50 value for HeLa cells was 0.737 ± 0.05 μM, whereas that for HT-29 cells was 1.194 ± 0.02 μM. Further investigations revealed that 5e significantly inhibited tumor cell colony formation and migration, and it exhibited antiadhesive effects on HeLa cells as well as antitubulin activity along with the induction of early apoptosis of HeLa and HT-29 cells. In addition, derivative 5e significantly reduced the cell mitochondrial membrane potential in a dose-dependent manner and induced early apoptosis of HeLa and HT-29 cells, indicating that 5e may serve as a lead compound for further drug discovery and development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3849-21-6